Home302440 • KRX
add
SK Bioscience Co Ltd
Previous close
₩45,100.00
Day range
₩44,650.00 - ₩46,300.00
Year range
₩35,800.00 - ₩61,500.00
Market cap
3.57T KRW
Avg Volume
120.64K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 154.56B | 594.00% |
Operating expense | 41.10B | 23.03% |
Net income | -7.47B | 45.58% |
Net profit margin | -4.83 | 92.16% |
Earnings per share | -95.00 | 46.93% |
EBITDA | 6.04B | 131.86% |
Effective tax rate | 70.50% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.18T | -5.57% |
Total assets | 2.90T | 51.30% |
Total liabilities | 861.71B | 280.42% |
Total equity | 2.04T | — |
Shares outstanding | 78.35M | — |
Price to book | 1.95 | — |
Return on assets | -1.32% | — |
Return on capital | -1.56% | — |
Cash Flow
Net change in cash
(KRW) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -7.47B | 45.58% |
Cash from operations | 62.75B | 298.77% |
Cash from investing | -75.30B | -224.25% |
Cash from financing | -1.84B | -102.39% |
Net change in cash | -6.96B | -106.45% |
Free cash flow | 49.77B | 144.83% |
About
SK Bioscience is a South Korean biotechnology company that produces vaccines and other products and is a subsidiary of SK Chemicals. Wikipedia
CEO
Founded
Jul 1, 2018
Website
Employees
984